PBSV Stock Overview
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Pharma-Bio Serv, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.60 |
| 52 Week High | US$0.99 |
| 52 Week Low | US$0.31 |
| Beta | 0.51 |
| 1 Month Change | 9.11% |
| 3 Month Change | 3.45% |
| 1 Year Change | -37.43% |
| 3 Year Change | -31.03% |
| 5 Year Change | -29.41% |
| Change since IPO | -52.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PBSV | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 3.3% | -1.2% | -0.9% |
| 1Y | -37.4% | -1.6% | 22.6% |
Return vs Industry: PBSV underperformed the US Life Sciences industry which returned -1.5% over the past year.
Return vs Market: PBSV underperformed the US Market which returned 24.3% over the past year.
Price Volatility
| PBSV volatility | |
|---|---|
| PBSV Average Weekly Movement | 20.2% |
| Life Sciences Industry Average Movement | 9.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: PBSV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PBSV's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 100 | Victor Sanchez | www.pbsvinc.com |
Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services, including regulatory compliance, validation, technology transfer, engineering, project management, and process support services. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Pharma-Bio Serv, Inc. Fundamentals Summary
| PBSV fundamental statistics | |
|---|---|
| Market cap | US$13.77m |
| Earnings (TTM) | -US$777.62k |
| Revenue (TTM) | US$9.51m |
1.4x
P/S Ratio-17.7x
P/E RatioIs PBSV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PBSV income statement (TTM) | |
|---|---|
| Revenue | US$9.51m |
| Cost of Revenue | US$6.99m |
| Gross Profit | US$2.52m |
| Other Expenses | US$3.29m |
| Earnings | -US$777.62k |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.034 |
| Gross Margin | 26.46% |
| Net Profit Margin | -8.18% |
| Debt/Equity Ratio | 0% |
How did PBSV perform over the long term?
See historical performance and comparisonDividends
37.5%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 01:07 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pharma-Bio Serv, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jack Wallace | Sidoti & Company, LLC |
| Bradley Sorensen | Zacks Small-Cap Research |
| Elizabeth Senko | Zacks Small-Cap Research |